A wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has entered into definitive agreements to invest USD 200 million for an approximately 3% stake in Micro Life Sciences Private Limited (Meril), one of India’s leading medical devices companies.
This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI).